Tamoxifen · Tamoxifen Citrate
Tamoxifen citrate, marketed primarily as Nolvadex, is an orally active selective estrogen receptor modulator (SERM) originally developed by ICI Pharmaceuticals (now AstraZeneca) in the 1960s and FDA-approved in 1977 for the treatment of metastatic breast cancer. It is a triphenylethylene derivative that acts as an estrogen receptor antagonist in breast tissue while displaying partial agonist activity in bone, liver, and endometrium. Tamoxifen remains one of the most widely used drugs in oncology and is on the World Health Organization's List of Essential Medicines.
For PCT, 20-40mg daily is standard, typically tapered over 4-6 weeks. For on-cycle gynecomastia prevention, 10-20mg daily is effective. A single daily dose works given the long half-life (5-7 days), though splitting is acceptable. Draw baseline labs (LH, FSH, total testosterone, free testosterone, estradiol) before starting and repeat at 4 and 8 weeks to confirm hormonal restart. Take with food if nausea occurs.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Tamoxifen is a prodrug metabolized primarily by CYP2D6 and CYP3A4 to the active metabolites 4-hydroxytamoxifen and endoxifen, which bind estrogen receptors (ER-alpha and ER-beta) with high affinity. In breast tissue and the hypothalamic-pituitary axis it acts as an antagonist, blocking estrogen-driven gene transcription. In bone, liver, and endometrium it behaves as a partial agonist, providing some estrogen-like protective effects on bone density and lipid profile.
The hypothalamic and pituitary blockade is the mechanistic basis for PCT use - by preventing estrogen's negative feedback on GnRH release, tamoxifen disinhibits LH and FSH secretion, which restimulates Leydig cells to produce testosterone and Sertoli cells to support spermatogenesis. Recovery of endogenous testosterone production after anabolic suppression typically occurs over 4-8 weeks on a tapered tamoxifen course.
For gynecomastia, direct receptor blockade in mammary tissue prevents proliferative signaling even when circulating estradiol is elevated from aromatization. Unlike AIs, tamoxifen does not reduce circulating estradiol - in fact estradiol often rises modestly during use - so AIs and SERMs treat two different mechanisms.
A commonly cited but underpowered concern is that tamoxifen may reduce serum IGF-1 levels by 15-25%, which has led some bodybuilders to avoid it during cycles where anabolic signaling matters. The clinical significance of this effect for muscle retention is debated and has not been conclusively established in randomized trials.
First 1-2 weeks: steady state builds given the long 5-7 day half-life. Initial nausea or stomach upset is common but typically resolves within a week. Subtle libido improvements begin as LH and FSH start to rise.
Weeks 2-4: measurable hormonal recovery - LH, FSH, and total testosterone trend upward. Gynecomastia symptoms regressing with consistent dosing. This is the window to check labs (LH, FSH, total and free testosterone, E2) to confirm HPT restart.
Weeks 4-8: testosterone typically back in the physiological range for men coming off a moderate cycle. Extended recovery (> 8 weeks) may be needed after long or heavy cycles. Full testicular responsiveness and sperm parameters can take several months to normalize.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Evidence boundary from the checked abstract: Tamoxifen decreases the incidence of invasive and noninvasive breast cancer.
Tamoxifen decreases the incidence of invasive and noninvasive breast cancer.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 20mg; Oral; 1-2x daily. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.
Primary safety claim: No primary safety text present in source JSON. No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.
(parent compound); active metabolite endoxifen ~14 days
(parent compound); 6-8+ weeks (endoxifen)
Oral (extensively metabolized first-pass to active metabolites)
Long half-life supports once-daily dosing. Steady state requires ~4 weeks; residual blockade persists 4-6 weeks after discontinuation
Hepatic (CYP2D6 primary, CYP3A4 secondary). Fecal excretion predominates; steady state reached in 4-6 weeks.
Storage. Store at controlled room temperature (20-25°C / 68-77°F). Protect from moisture and light. Keep in original container. Shelf life typically 4-5 years from manufacture date for tablets. Research-grade oral suspensions should be refrigerated after opening and used within 30-60 days. Keep out of reach of children.
Prescription medication (Rx) in the United States. FDA-approved brand: Nolvadex (historically AstraZeneca, now largely generic). Generic tamoxifen citrate is widely available. Not a controlled substance. Off-label use in men for PCT or gynecomastia is common but legally requires a valid prescription. Research liquid forms marketed for research purposes are not FDA-regulated for human use. Internationally classified as a prescription drug; on the WHO List of Essential Medicines in most formulary lists.
Put it to work
Open Nolvadex (Tamoxifen Citrate) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Nolvadex (Tamoxifen Citrate) in the app →Go deeper
The complete Nolvadex (Tamoxifen Citrate) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.